sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Automotive / AI in Drug Discovery

AI in Drug Discovery Market By Drug Type (Small Molecule and Large Molecule), By Technology (Deep Learning, Machine Learning, Others), By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Academic & Research Institutes, and Others), By Therapeutic Area (Metabolic Diseases, Cardiovascular Diseases, Immuno-Oncology, Oncology, Neurodegenerative Diseases, Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020–2026

  • Publish On: Feb-2020
  • Total Pages: 110
  • Report Code: FAF-414
  • Base Year: 2019
  • Format:

Industry Insights

The report encompasses the forecast as well as analysis of the AI in the Drug Discovery market on a global and regional level. The study displays historical data of 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). Additionally, the market growth drivers, opportunities, restraints, and trends are also included in the AI in the Drug Discovery market report.

We have encompassed industry analysis models in our report and extensively demonstrated the key business strategies and competitive landscape of the AI in the Drug Discovery market in our study.

Our study also includes an analysis of Porter’s Five Forces framework for understanding the competitive strategies used by market competitors. It also encompasses PESTLE analysis and SWOT analysis.

The report also offers an in-depth analysis of the market share of each industry player and gives an outline of the market position of key players in the AI in the Drug Discovery market. Moreover, the study offers wide coverage of key strategic improvements witnessed in the market such as acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, R&D activities, and geographical expansion of key players of the AI in Drug Discovery market.

The study provides a decisive view of the AI in the Drug Discovery market by segmenting the AI in the Drug Discovery market based on drug type, technology, end-user, therapeutic area, and regions. All the segments and sub-segments have been examined based on historic, current and future trends in the global market and the market size is estimated from 2020 to 2026 in terms of value. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

An AI in Drug Discovery is used to identify targets, in silico drug design, drug development, predictive analytics, research risk assessment, clinical tracking and even more.

Machine learning may help maximize treatment by combining biological and clinical evidence with mathematical models and can be used to develop drug testing and probabilistic treatment applications. Computational deep learning research indicates this methodology should be helpful in finding complex models in results. Since biological and clinical data are diverse, deterministic quantic machine learning algorithms offer a reasonable opportunity to advance interpret them. However,  one of the major challenges in the drug discovery phase is patient health.

 The global AI in the Drug Discovery market is segmented into drug type, technology, end-user, therapeutic area, and region. On the basis of drug type, the global AI in the Drug Discovery market is classified as a small molecule and large molecule. The small molecule segment is expected to record the fastest growth over the predictable period, due to its advantages over the large molecule. On the basis of technology, the global AI in the Drug Discovery market is bifurcated into deep learning, machine learning and others where machine learning is more dominating over the predictable period. On the basis of end-user, the global AI in the Drug Discovery market is divided into pharmaceutical companies, biopharmaceutical companies, academic, and research institutes and others where pharmaceutical companies are leading. The global AI in the Drug Discovery industry is categorized into metabolic diseases, cardiovascular diseases, immuno-oncology, neurodegenerative diseases and others where oncology is at the front, depending on therapeutic areas.

Key players operating in the AI in the Drug Discovery industry are Atomwise Inc, BenevolentAI, Bio age, Cloud Pharmaceuticals Inc, Exscientia Ltd, Insilico Medicine Inc, Numerate Inc, Envisagenics Inc, Two XAR Inc, Accutar Biotechnology Inc, Recursion Pharmaceuticals Inc, Silicon Therapeutics LLC, AstraZeneca PLC.

This report segments the AI in Drug Discovery market as follows:

Global AI in Drug Discovery Market: By Drug Type Segment Analysis

  • small molecule
  • large molecule

Global AI in Drug Discovery Market: By Technology Segment Analysis

  • deep learning
  • machine learning
  • other segments

Global AI in Drug Discovery Market: By End-user Segment Analysis

  • pharmaceutical companies
  • biopharmaceutical companies
  • academic and research institutions

Global AI in Drug Discovery Market: By Therapeutic Area Segment Analysis

  • metabolic disease
  • cardiovascular disease
  • immuno-oncology
  • oncology
  • neurodegenerative diseases

Global AI in Drug Discovery Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-East Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • The Middle-East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle-East Africa

Key Pointers Addressed by the Report

  • Historical data and forecast analysis of the market
  • Drivers and Restraints affecting market dynamics
  • Exhaustive analysis about the future market trends
  • Comprehensive information about the leading market segments and regions
  • Potential opportunities for the players in the market
  • Business strategies by the major players operating in the global market
  • Strategic developments made by the competitive players and in-depth analysis about its impact on market growth

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. AI in Drug Discovery market – Drug Type Analysis
    1. 2.1. Global AI in Drug Discovery Market – Drug Type Overview
    2. 2.2. Global AI in Drug Discovery Market Share, by Drug Type , 2018 & 2025 (USD Million)
    3. 2.3. small molecule
      1. 2.3.1. Global small molecule AI in Drug Discovery Market, 2016-2026 (USD Million)
    4. 2.4. large molecule
      1. 2.4.1. Global large molecule AI in Drug Discovery Market, 2016-2026 (USD Million)
  3. CHAPTER 3. AI in Drug Discovery market – Technology Analysis
    1. 3.1. Global AI in Drug Discovery Market – Technology Overview
    2. 3.2. Global AI in Drug Discovery Market Share, by Technology , 2018 & 2025 (USD Million)
    3. 3.3. deep learning
      1. 3.3.1. Global deep learning AI in Drug Discovery Market, 2016-2026 (USD Million)
    4. 3.4. machine learning
      1. 3.4.1. Global machine learning AI in Drug Discovery Market, 2016-2026 (USD Million)
    5. 3.5. other segments
      1. 3.5.1. Global other segments AI in Drug Discovery Market, 2016-2026 (USD Million)
  4. CHAPTER 4. AI in Drug Discovery market – End-user Analysis
    1. 4.1. Global AI in Drug Discovery Market – End-user Overview
    2. 4.2. Global AI in Drug Discovery Market Share, by End-user , 2018 & 2025 (USD Million)
    3. 4.3. pharmaceutical companies
      1. 4.3.1. Global pharmaceutical companies AI in Drug Discovery Market, 2016-2026 (USD Million)
    4. 4.4. biopharmaceutical companies
      1. 4.4.1. Global biopharmaceutical companies AI in Drug Discovery Market, 2016-2026 (USD Million)
    5. 4.5. academic and research institutions
      1. 4.5.1. Global academic and research institutions AI in Drug Discovery Market, 2016-2026 (USD Million)
  5. CHAPTER 5. AI in Drug Discovery market – Therapeutic Area Analysis
    1. 5.1. Global AI in Drug Discovery Market – Therapeutic Area Overview
    2. 5.2. Global AI in Drug Discovery Market Share, by Therapeutic Area , 2018 & 2025 (USD Million)
    3. 5.3. metabolic disease
      1. 5.3.1. Global metabolic disease AI in Drug Discovery Market, 2016-2026 (USD Million)
    4. 5.4. cardiovascular disease
      1. 5.4.1. Global cardiovascular disease AI in Drug Discovery Market, 2016-2026 (USD Million)
    5. 5.5. immuno-oncology
      1. 5.5.1. Global immuno-oncology AI in Drug Discovery Market, 2016-2026 (USD Million)
    6. 5.6. oncology
      1. 5.6.1. Global oncology AI in Drug Discovery Market, 2016-2026 (USD Million)
    7. 5.7. neurodegenerative diseases
      1. 5.7.1. Global neurodegenerative diseases AI in Drug Discovery Market, 2016-2026 (USD Million)
  6. CHAPTER 6. AI in Drug Discovery market – Regional Analysis
    1. 6.1. Global AI in Drug Discovery Market Regional Overview
    2. 6.2. Global AI in Drug Discovery Market Share, by Region, 2018 & 2025 (Value)
    3. 6.3. North America
      1. 6.3.1. North America AI in Drug Discovery Market size and forecast, 2016-2026
      2. 6.3.2. North America AI in Drug Discovery Market, by Country, 2018 & 2025 (USD Million)
      3. 6.3.3. North America AI in Drug Discovery Market, by Drug Type , 2016-2026
        1. 6.3.3.1. North America AI in Drug Discovery Market, by Drug Type , 2016-2026 (USD Million)
      4. 6.3.4. North America AI in Drug Discovery Market, by Technology , 2016-2026
        1. 6.3.4.1. North America AI in Drug Discovery Market, by Technology , 2016-2026 (USD Million)
      5. 6.3.5. North America AI in Drug Discovery Market, by End-user , 2016-2026
        1. 6.3.5.1. North America AI in Drug Discovery Market, by End-user , 2016-2026 (USD Million)
      6. 6.3.6. North America AI in Drug Discovery Market, by Therapeutic Area , 2016-2026
        1. 6.3.6.1. North America AI in Drug Discovery Market, by Therapeutic Area , 2016-2026 (USD Million)
      7. 6.3.7. U.S.
        1. 6.3.7.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      8. 6.3.8. Canada
        1. 6.3.8.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 6.4. Europe
      1. 6.4.1. Europe AI in Drug Discovery Market size and forecast, 2016-2026
      2. 6.4.2. Europe AI in Drug Discovery Market, by Country, 2018 & 2025 (USD Million)
      3. 6.4.3. Europe AI in Drug Discovery Market, by Drug Type , 2016-2026
        1. 6.4.3.1. Europe AI in Drug Discovery Market, by Drug Type , 2016-2026 (USD Million)
      4. 6.4.4. Europe AI in Drug Discovery Market, by Technology , 2016-2026
        1. 6.4.4.1. Europe AI in Drug Discovery Market, by Technology , 2016-2026 (USD Million)
      5. 6.4.5. Europe AI in Drug Discovery Market, by End-user , 2016-2026
        1. 6.4.5.1. Europe AI in Drug Discovery Market, by End-user , 2016-2026 (USD Million)
      6. 6.4.6. Europe AI in Drug Discovery Market, by Therapeutic Area , 2016-2026
        1. 6.4.6.1. Europe AI in Drug Discovery Market, by Therapeutic Area , 2016-2026 (USD Million)
      7. 6.4.7. Germany
        1. 6.4.7.1. Germany Market size and forecast, 2016-2026 (USD Million)
      8. 6.4.8. France
        1. 6.4.8.1. France Market size and forecast, 2016-2026 (USD Million)
      9. 6.4.9. U.K.
        1. 6.4.9.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      10. 6.4.10. Italy
        1. 6.4.10.1. Italy Market size and forecast, 2016-2026 (USD Million)
      11. 6.4.11. Spain
        1. 6.4.11.1. Spain Market size and forecast, 2016-2026 (USD Million)
      12. 6.4.12. Rest of Europe
        1. 6.4.12.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 6.5. Asia Pacific
      1. 6.5.1. Asia Pacific AI in Drug Discovery Market size and forecast, 2016-2026
      2. 6.5.2. Asia Pacific AI in Drug Discovery Market, by Country, 2018 & 2025 (USD Million)
      3. 6.5.3. Asia Pacific AI in Drug Discovery Market, by Drug Type , 2016-2026
        1. 6.5.3.1. Asia Pacific AI in Drug Discovery Market, by Drug Type , 2016-2026 (USD Million)
      4. 6.5.4. Asia Pacific AI in Drug Discovery Market, by Technology , 2016-2026
        1. 6.5.4.1. Asia Pacific AI in Drug Discovery Market, by Technology , 2016-2026 (USD Million)
      5. 6.5.5. Asia Pacific AI in Drug Discovery Market, by End-user , 2016-2026
        1. 6.5.5.1. Asia Pacific AI in Drug Discovery Market, by End-user , 2016-2026 (USD Million)
      6. 6.5.6. Asia Pacific AI in Drug Discovery Market, by Therapeutic Area , 2016-2026
        1. 6.5.6.1. Asia Pacific AI in Drug Discovery Market, by Therapeutic Area , 2016-2026 (USD Million)
      7. 6.5.7. China
        1. 6.5.7.1. China Market size and forecast, 2016-2026 (USD Million)
      8. 6.5.8. Japan
        1. 6.5.8.1. Japan Market size and forecast, 2016-2026 (USD Million)
      9. 6.5.9. India
        1. 6.5.9.1. India Market size and forecast, 2016-2026 (USD Million)
      10. 6.5.10. South Korea
        1. 6.5.10.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      11. 6.5.11. South-East Asia
        1. 6.5.11.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      12. 6.5.12. Rest of Asia Pacific
        1. 6.5.12.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 6.6. Latin America
      1. 6.6.1. Latin America AI in Drug Discovery Market size and forecast, 2016-2026
      2. 6.6.2. Latin America AI in Drug Discovery Market, by Country, 2018 & 2025 (USD Million)
      3. 6.6.3. Latin America AI in Drug Discovery Market, by Drug Type , 2016-2026
        1. 6.6.3.1. Latin America AI in Drug Discovery Market, by Drug Type , 2016-2026 (USD Million)
      4. 6.6.4. Latin America AI in Drug Discovery Market, by Technology , 2016-2026
        1. 6.6.4.1. Latin America AI in Drug Discovery Market, by Technology , 2016-2026 (USD Million)
      5. 6.6.5. Latin America AI in Drug Discovery Market, by End-user , 2016-2026
        1. 6.6.5.1. Latin America AI in Drug Discovery Market, by End-user , 2016-2026 (USD Million)
      6. 6.6.6. Latin America AI in Drug Discovery Market, by Therapeutic Area , 2016-2026
        1. 6.6.6.1. Latin America AI in Drug Discovery Market, by Therapeutic Area , 2016-2026 (USD Million)
      7. 6.6.7. Brazil
        1. 6.6.7.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      8. 6.6.8. Mexico
        1. 6.6.8.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      9. 6.6.9. Rest of Latin America
        1. 6.6.9.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 6.7. The Middle-East and Africa
      1. 6.7.1. The Middle-East and Africa AI in Drug Discovery Market size and forecast, 2016-2026
      2. 6.7.2. The Middle-East and Africa AI in Drug Discovery Market, by Country, 2018 & 2025 (USD Million)
      3. 6.7.3. The Middle-East and Africa AI in Drug Discovery Market, by Drug Type , 2016-2026
        1. 6.7.3.1. The Middle-East and Africa AI in Drug Discovery Market, by Drug Type , 2016-2026 (USD Million)
      4. 6.7.4. The Middle-East and Africa AI in Drug Discovery Market, by Technology , 2016-2026
        1. 6.7.4.1. The Middle-East and Africa AI in Drug Discovery Market, by Technology , 2016-2026 (USD Million)
      5. 6.7.5. The Middle-East and Africa AI in Drug Discovery Market, by End-user , 2016-2026
        1. 6.7.5.1. The Middle-East and Africa AI in Drug Discovery Market, by End-user , 2016-2026 (USD Million)
      6. 6.7.6. The Middle-East and Africa AI in Drug Discovery Market, by Therapeutic Area , 2016-2026
        1. 6.7.6.1. The Middle-East and Africa AI in Drug Discovery Market, by Therapeutic Area , 2016-2026 (USD Million)
      7. 6.7.7. GCC Countries
        1. 6.7.7.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      8. 6.7.8. South Africa
        1. 6.7.8.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      9. 6.7.9. Rest of Middle-East Africa
        1. 6.7.9.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  7. CHAPTER 7. AI in Drug Discovery market – Competitive Landscape
    1. 7.1. Competitor Market Share – Revenue
    2. 7.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 7.3. Strategic Development
      1. 7.3.1. Acquisitions and Mergers
      2. 7.3.2. New Products
      3. 7.3.3. Research & Development Activities
  8. CHAPTER 8. Company Profiles
    1. 8.1. Atomwise Inc
      1. 8.1.1. Company Overview
      2. 8.1.2. Atomwise Inc Revenue and Gross Margin
      3. 8.1.3. Product portfolio
      4. 8.1.4. Recent initiatives
    2. 8.2. BenevolentAI
      1. 8.2.1. Company Overview
      2. 8.2.2. BenevolentAI Revenue and Gross Margin
      3. 8.2.3. Product portfolio
      4. 8.2.4. Recent initiatives
    3. 8.3. Bioage
      1. 8.3.1. Company Overview
      2. 8.3.2. Bioage Revenue and Gross Margin
      3. 8.3.3. Product portfolio
      4. 8.3.4. Recent initiatives
    4. 8.4. Cloud Pharmaceuticals, Inc
      1. 8.4.1. Company Overview
      2. 8.4.2. Cloud Pharmaceuticals, Inc Revenue and Gross Margin
      3. 8.4.3. Product portfolio
      4. 8.4.4. Recent initiatives
    5. 8.5. Exscientia Ltd
      1. 8.5.1. Company Overview
      2. 8.5.2. Exscientia Ltd Revenue and Gross Margin
      3. 8.5.3. Product portfolio
      4. 8.5.4. Recent initiatives
    6. 8.6. Insilico Medicine, Inc
      1. 8.6.1. Company Overview
      2. 8.6.2. Insilico Medicine, Inc Revenue and Gross Margin
      3. 8.6.3. Product portfolio
      4. 8.6.4. Recent initiatives
    7. 8.7. Numerate, Inc
      1. 8.7.1. Company Overview
      2. 8.7.2. Numerate, Inc Revenue and Gross Margin
      3. 8.7.3. Product portfolio
      4. 8.7.4. Recent initiatives
    8. 8.8. Envisagenics, Inc
      1. 8.8.1. Company Overview
      2. 8.8.2. Envisagenics, Inc Revenue and Gross Margin
      3. 8.8.3. Product portfolio
      4. 8.8.4. Recent initiatives
    9. 8.9. Two XAR, Inc
      1. 8.9.1. Company Overview
      2. 8.9.2. Two XAR, Inc Revenue and Gross Margin
      3. 8.9.3. Product portfolio
      4. 8.9.4. Recent initiatives
    10. 8.10. Accutar Biotechnology, Inc
      1. 8.10.1. Company Overview
      2. 8.10.2. Accutar Biotechnology, Inc Revenue and Gross Margin
      3. 8.10.3. Product portfolio
      4. 8.10.4. Recent initiatives
    11. 8.11. Recursion Pharmaceuticals, Inc
      1. 8.11.1. Company Overview
      2. 8.11.2. Recursion Pharmaceuticals, Inc Revenue and Gross Margin
      3. 8.11.3. Product portfolio
      4. 8.11.4. Recent initiatives
    12. 8.12. Silicon Therapeutics LLC
      1. 8.12.1. Company Overview
      2. 8.12.2. Silicon Therapeutics LLC Revenue and Gross Margin
      3. 8.12.3. Product portfolio
      4. 8.12.4. Recent initiatives
    13. 8.13. AstraZeneca PLC
      1. 8.13.1. Company Overview
      2. 8.13.2. AstraZeneca PLC Revenue and Gross Margin
      3. 8.13.3. Product portfolio
      4. 8.13.4. Recent initiatives
  9. CHAPTER 9. AI in Drug Discovery — Industry Analysis
    1. 9.1. AI in Drug Discovery Market – Key Trends
      1. 9.1.1. Market Drivers
      2. 9.1.2. Market Restraints
      3. 9.1.3. Market Opportunities
    2. 9.2. Value Chain Analysis
    3. 9.3. Technology Roadmap and Timeline
    4. 9.4. AI in Drug Discovery Market – Attractiveness Analysis
      1. 9.4.1. By Drug Type
      2. 9.4.2. By Technology
      3. 9.4.3. By End-user
      4. 9.4.4. By Therapeutic Area
      5. 9.4.5. By Region
  10. CHAPTER 10. Marketing Strategy Analysis, Distributors
    1. 10.1. Marketing Channel
    2. 10.2. Direct Marketing
    3. 10.3. Indirect Marketing
    4. 10.4. Marketing Channel Development Trend
    5. 10.5. Economic/Political Environmental Change
  11. CHAPTER 11. Report Conclusion
  12. CHAPTER 12. Research Approach & Methodology
    1. 12.1. Report Description
    2. 12.2. Research Scope
    3. 12.3. Research Methodology
      1. 12.3.1. Secondary Research
      2. 12.3.2. Primary Research
      3. 12.3.3. Models
        1. 12.3.3.1. Company Share Analysis Model
        2. 12.3.3.2. Revenue Based Modeling
        3. 12.3.3.3. Research Limitations

        List of Figures

        FIG. 1    Global AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 2    Global AI in Drug Discovery  Market Share, by Drug Type , 2018 & 2025 (USD Million)
        FIG. 3    Global small molecule  AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 4    Global large molecule  AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 5    Global AI in Drug Discovery  Market Share, by Technology , 2018 & 2025 (USD Million)
        FIG. 6    Global deep learning AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 7    Global machine learning  AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 8    Global other segments  AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 9    Global AI in Drug Discovery  Market Share, by End-user , 2018 & 2025 (USD Million)
        FIG. 10    Global pharmaceutical companies  AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 11    Global biopharmaceutical companies AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 12    Global academic and research institutions  AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 13    Global AI in Drug Discovery  Market Share, by Therapeutic Area , 2018 & 2025 (USD Million)
        FIG. 14    Global metabolic disease  AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 15    Global cardiovascular disease  AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 16    Global immuno-oncology  AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 17    Global oncology AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 18    Global neurodegenerative diseases AI in Drug Discovery  Market, 2016-2026 (USD Million)
        FIG. 19    Global AI in Drug Discovery  Market Share, by Region, 2018 & 2025
        FIG. 20    North America AI in Drug Discovery  Market, 2016-2026
        FIG. 21    U.S. AI in Drug Discovery  Market, 2016-2026
        FIG. 22    Canada AI in Drug Discovery  Market, 2016-2026
        FIG. 23    Europe AI in Drug Discovery  Market, 2016-2026
        FIG. 24    Germany AI in Drug Discovery  Market, 2016-2026
        FIG. 25    France AI in Drug Discovery  Market, 2016-2026
        FIG. 26    U.K. AI in Drug Discovery  Market, 2016-2026
        FIG. 27    Italy AI in Drug Discovery  Market, 2016-2026
        FIG. 28    Spain AI in Drug Discovery  Market, 2016-2026
        FIG. 29    Rest of Europe AI in Drug Discovery  Market, 2016-2026
        FIG. 30    Asia Pacific AI in Drug Discovery  Market, 2016-2026
        FIG. 31    China AI in Drug Discovery  Market, 2016-2026
        FIG. 32    Japan AI in Drug Discovery  Market, 2016-2026
        FIG. 33    India AI in Drug Discovery  Market, 2016-2026
        FIG. 34    South  Korea AI in Drug Discovery  Market, 2016-2026
        FIG. 35    South-East Asia AI in Drug Discovery  Market, 2016-2026
        FIG. 36    Rest of Asia Pacific AI in Drug Discovery  Market, 2016-2026
        FIG. 37    Latin America AI in Drug Discovery  Market, 2016-2026
        FIG. 38    Brazil AI in Drug Discovery  Market, 2016-2026
        FIG. 39    Mexico AI in Drug Discovery  Market, 2016-2026
        FIG. 40    Rest of Latin America AI in Drug Discovery  Market, 2016-2026
        FIG. 41    The Middle-East and Africa AI in Drug Discovery  Market, 2016-2026
        FIG. 42    GCC Countries AI in Drug Discovery  Market, 2016-2026
        FIG. 43    South Africa AI in Drug Discovery  Market, 2016-2026
        FIG. 44    Rest of Middle-East Africa AI in Drug Discovery  Market, 2016-2026
        FIG. 45    Competitor Market Share – Revenue
        FIG. 46    Atomwise Inc Revenue and Growth Rate
        FIG. 47    Atomwise Inc Market Share
        FIG. 48    BenevolentAI Revenue and Growth Rate
        FIG. 49    BenevolentAI Market Share
        FIG. 50    Bioage Revenue and Growth Rate
        FIG. 51    Bioage Market Share
        FIG. 52    Cloud Pharmaceuticals, Inc Revenue and Growth Rate
        FIG. 53    Cloud Pharmaceuticals, Inc Market Share
        FIG. 54    Exscientia Ltd Revenue and Growth Rate
        FIG. 55    Exscientia Ltd Market Share
        FIG. 56    Insilico Medicine, Inc Revenue and Growth Rate
        FIG. 57    Insilico Medicine, Inc Market Share
        FIG. 58    Numerate, Inc Revenue and Growth Rate
        FIG. 59    Numerate, Inc Market Share
        FIG. 60    Envisagenics, Inc Revenue and Growth Rate
        FIG. 61    Envisagenics, Inc Market Share
        FIG. 62    Two XAR, Inc Revenue and Growth Rate
        FIG. 63    Two XAR, Inc Market Share
        FIG. 64    Accutar Biotechnology, Inc Revenue and Growth Rate
        FIG. 65    Accutar Biotechnology, Inc Market Share
        FIG. 66    Recursion Pharmaceuticals, Inc Revenue and Growth Rate
        FIG. 67    Recursion Pharmaceuticals, Inc Market Share
        FIG. 68    Silicon Therapeutics LLC Revenue and Growth Rate
        FIG. 69    Silicon Therapeutics LLC Market Share
        FIG. 70    AstraZeneca PLC Revenue and Growth Rate
        FIG. 71    AstraZeneca PLC Market Share
        FIG. 72    Market Dynamics
        FIG. 73    Global AI in Drug Discovery  – Value Chain Analysis
        FIG. 74    Technology Roadmap and Timeline
        FIG. 75    Market Attractiveness Analysis – By Drug Type
        FIG. 76    Market Attractiveness Analysis – By Technology
        FIG. 77    Market Attractiveness Analysis – By End-user
        FIG. 78    Market Attractiveness Analysis – By Therapeutic Area
        FIG. 79    Market Attractiveness Analysis – By Region
        FIG. 80    Market Channel
        FIG. 81    Marketing Channel Development Trend
        FIG. 82    Growth in World Gross Product, 2008-2018


        List of Tables

        TABLE 1    Global AI in Drug Discovery  Market, 2018 & 2025 (USD Million)
        TABLE 2    Global AI in Drug Discovery  Market, by Drug Type , 2016-2026 (USD Million)
        TABLE 3    Global AI in Drug Discovery  Market, by Technology , 2016-2026 (USD Million)
        TABLE 4    Global AI in Drug Discovery  market, by End-user, 2016-2026 (USD Million)
        TABLE 5    Global AI in Drug Discovery  market, by Therapeutic Area, 2016-2026 (USD Million)
        TABLE 6    Global AI in Drug Discovery  Market, by Region, 2016-2026 (USD Million)
        TABLE 7    North America AI in Drug Discovery  Market, by Drug Type, 2016-2026 (USD Million)
        TABLE 8    North America AI in Drug Discovery  Market, by Technology, 2016-2026 (USD Million)
        TABLE 9    North America AI in Drug Discovery  Market, by End-user, 2016-2026 (USD Million)
        TABLE 10    North America AI in Drug Discovery  Market, by Therapeutic Area, 2016-2026 (USD Million)
        TABLE 11    Europe AI in Drug Discovery  Market, by Drug Type, 2016-2026 (USD Million)
        TABLE 12    Europe AI in Drug Discovery  Market, by Technology, 2016-2026 (USD Million)
        TABLE 13    Europe AI in Drug Discovery  Market, by End-user, 2016-2026 (USD Million)
        TABLE 14    Europe AI in Drug Discovery  Market, by Therapeutic Area, 2016-2026 (USD Million)
        TABLE 15    Asia Pacific AI in Drug Discovery  Market, by Drug Type, 2016-2026 (USD Million)
        TABLE 16    Asia Pacific AI in Drug Discovery  Market, by Technology, 2016-2026 (USD Million)
        TABLE 17    Asia Pacific AI in Drug Discovery  Market, by End-user, 2016-2026 (USD Million)
        TABLE 18    Asia Pacific AI in Drug Discovery  Market, by Therapeutic Area, 2016-2026 (USD Million)
        TABLE 19    Latin America AI in Drug Discovery  Market, by Drug Type, 2016-2026 (USD Million)
        TABLE 20    Latin America AI in Drug Discovery  Market, by Technology, 2016-2026 (USD Million)
        TABLE 21    Latin America AI in Drug Discovery  Market, by End-user, 2016-2026 (USD Million)
        TABLE 22    Latin America AI in Drug Discovery  Market, by Therapeutic Area, 2016-2026 (USD Million)
        TABLE 23    The Middle-East and Africa AI in Drug Discovery  Market, by Drug Type, 2016-2026 (USD Million)
        TABLE 24    The Middle-East and Africa AI in Drug Discovery  Market, by Technology, 2016-2026 (USD Million)
        TABLE 25    The Middle-East and Africa AI in Drug Discovery  Market, by End-user, 2016-2026 (USD Million)
        TABLE 26    The Middle-East and Africa AI in Drug Discovery  Market, by Therapeutic Area, 2016-2026 (USD Million)
        TABLE 27    Global AI in Drug Discovery  Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 28    Global AI in Drug Discovery  Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 29    Acquisitions and Mergers
        TABLE 30    New Product/Service Launch
        TABLE 31    Research & Development Activities
        TABLE 32    Market Drivers
        TABLE 33    Market Restraints
        TABLE 34    Market Opportunities

Key Insights from Primary Research

  • According to our primary respondents, we have analyzed that the global AI in the Drug Discovery market is anticipated to grow annually with a CAGR of nearly 39% till 2026 end.
  • It was established through primary research that the global AI in the Drug Discovery market was valued at around USD 830 million in 2019.
  • On the basis of drug type, the small molecule led the market in 2019 accounting for around 60% share, in 2019
  • Based on technology, the machine learning segment held the largest share in the global AI in the Drug Discovery market, accounted for approximately 50% share in the global market in 2019.
  • By the end-user, the pharmaceutical companies segment held a major share in the global AI in the Drug Discovery market in 2019 and is projected to maintain a similar trend over the forecasted period.
  • On the basis of therapeutic area segmentation, the oncology category held the leading share of around 25% in 2019.
  • On the basis of region segmentation, the North America region held the leading share of around 50% in 2019.

Key Recommendations from Analysts

  • Our analysts predict that the global AI in the Drug Discovery market is probable to reach a market value of USD 12,000 million in 2026 and was valued at around USD 830 Million in 2019.
  • Drug companies rapidly understand the importance of introducing systems focused on Artificial Intelligence (AI) that can exploit data on gene variants, receptor targets, metabolic enzymes, disease events, and clinical studies to find hidden associations in drug-disease, this is a key factor in fueling the market growth globally.
  • By therapeutic area type, the oncology segment is anticipated to grow at a rate of around 4 % over the projected period, due to soaring growth in the oncology treatment.
  • Our analysts anticipate that the market to witness the fastest growth between 2023-2026 is the North American region due to the rise in spending on using Artificial Intelligence. This growing investment by pharmaceuticals companies is expected to drive the global AI in the Drug Discovery market.

Market Attractiveness-By Therapeutic Area

AI-in-Drug-Discovery-Market

Industry Major Market Players

  • Atomwise Inc
  • BenevolentAI
  • Bio age
  • Cloud Pharmaceuticals Inc
  • Exscientia Ltd
  • Insilico Medicine Inc
  • Numerate Inc
  • Envisagenics Inc
  • Two XAR Inc
  • Accutar Biotechnology Inc
  • Recursion Pharmaceuticals Inc
  • Silicon Therapeutics LLC
  • AstraZeneca PLC.

Related Reports

Track Dumper Market By Type (Mini Track Dumper, and Large Track Dumper), By Application (Construction and Mining, Utility Industry, and Others (Agricultural Activities, Road Construction, Forestry Commission Work, etc.)): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

[185+ Pages PDF Report] Global track dumper market was approximately USD 300.00 Million in 2019 and is anticipated to reach USD 400.00 Million by 2026, at a CAGR of 4.0% during the forecast period. This specialized and expertise oriented industry research report scrutinizes the technical and com...Read More

Nov-2020 | Price : $ 3850.00 | Pages: 185 | Report Code: ZMR-1339 | Report Format:

Under Vehicle Surveillance Systems Market By Type (Fixed, Portable) and By End Users (Military & Defense, Government, Commercial and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

[225+ PDF pages Report] Global Under Vehicle Surveillance Systems market expected USD 6.9 Billion and is anticipated to reach over USD 12.8 Billion by 2026, at a CAGR of 10.84%. This specializedandexpertise oriented industry research report scrutinizes the technical and commercial business outlo...Read More

Oct-2020 | Price : $ 3850.00 | Pages: 225 | Report Code: ZMR-1334 | Report Format:

Fire Truck Market By Type (Rescue Trucks, Tanker, Pumper, and Multi-Tasking Trucks) and By Application (Residential & Commercial, Enterprises & Airports, Military, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the fire truck industry. The report analyzes and declares the historical and current trends analysis of the Fire truck industry and subsequently recommends the projected tr...Read More

Sep-2020 | Price : $ 3850.00 | Pages: 192 | Report Code: ZMR-1306 | Report Format:

E-Bike Sharing Market By Type (Public Organization & Government, Private Company) and By Industry (Internal Use, and Public Use): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the e-bike sharing industry. The report analyzes and declares the historical and current trends analysis of the e-bike sharing industry and subsequently recommends the proj...Read More

Jun-2020 | Price : $ 3850.00 | Pages: 180 | Report Code: ZMR-1178 | Report Format:

Automotive Adhesive Tapes Market By Product (Double-sided tapes, Masking tapes, Reinforced tapes, and Specialty tapes), By Application (Interior, and Exterior) and By Backing Material (Polypropylene, Paper, and Polyvinyl Chloride): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the Automotive Adhesive Tapes industry. The report analyzes and declares the historical and current trends analysis of the Automotive Adhesive Tapes industry and subsequent...Read More

Jun-2020 | Price : $ 3850.00 | Pages: 189 | Report Code: ZMR-1175 | Report Format:

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions